CD86 and lung cancer: reported that in a mouse lung cancer model treatment with a nano-formulated combination of R848 and Poly I:C reprogrammed tumor-associated macrophages by increasing the M1 (F4/80+,CD86+) by M2 (F4/80+,Arg1+) ratio and suppressing tumor progression.